|
INE1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.580800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.711400E-01 |
| Normal-vs-Stage2 |
6.592000E-01 |
| Normal-vs-Stage3 |
9.485900E-02 |
| Normal-vs-Stage4 |
2.985600E-01 |
| Stage1-vs-Stage2 |
6.169600E-01 |
| Stage1-vs-Stage3 |
4.190800E-04 |
| Stage1-vs-Stage4 |
2.399000E-01 |
| Stage2-vs-Stage3 |
7.214400E-02 |
| Stage2-vs-Stage4 |
1.856610E-01 |
| Stage3-vs-Stage4 |
5.583400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.981800E-01 |
| Normal-vs-AfricanAmerican |
8.986400E-01 |
| Normal-vs-Asian |
8.262600E-01 |
| Caucasian-vs-AfricanAmerican |
8.308400E-01 |
| Caucasian-vs-Asian |
7.217800E-01 |
| AfricanAmerican-vs-Asian |
8.350200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.632600E-01 |
| Normal-vs-Female |
4.929000E-01 |
| Male-vs-Female |
1.256430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.347400E-01 |
| Normal-vs-Extreme_Weight |
8.720000E-01 |
| Normal-vs-Obese |
8.622000E-01 |
| Normal-vs-Extreme_Obese |
9.421800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.048000E-01 |
| Normal_Weight-vs-Obese |
7.254200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.520000E-01 |
| Extreme_Weight-vs-Obese |
5.924200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.003400E-01 |
| Obese-vs-Extreme_Obese |
9.710800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.928600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.559000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.039200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.528200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.958600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.842600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.198350E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.340980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.630100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.674800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.437000E-01 |
| Normal-VS-Type2 PRCC |
8.675600E-02 |
| Normal-VS-KIRP CIMP |
1.309580E-01 |
| Normal-VS-Unclassified PRCC |
8.109800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.03540001204084E-09 |
| Type1 PRCC-VS-KIRP CIMP |
1.855550E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.536800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.358400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.367720E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.721800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.077200E-01 |
| Normal-vs-N1 |
4.828400E-01 |
| Normal-vs-N2 |
2.245600E-01 |
| N0-vs-N1 |
8.983800E-01 |
| N0-vs-N2 |
4.905400E-01 |
| N1-vs-N2 |
4.808000E-01 |
|
|
